generic drugs

Showing 11 posts of 11 posts found.


Novartis’ subsidiary Sandoz agrees to pay $195 million to settle antitrust case

March 3, 2020
Manufacturing and Production Novartis, US Courts, generic drugs, generics, price fixing, price-fixing

Novartis’ Sandoz will pay a $195 million criminal penalty to resolve charges that it conspired to price-fix, rig bids and …


FDA approved over 1,000 generic drugs in 2019

February 20, 2020
Research and Development, Sales and Marketing FDA, generic drugs, pharma

The FDA covered a lot of ground in 2019 when it came to generic drugs, awarding at least tentative approval …


2019 saw the FDA approve more generic drugs than ever before

October 18, 2019
Medical Communications, Sales and Marketing FDA, US, generic drugs, pharma

Fiscal year 2019 was a record-breaking one, according to the FDA. The US regulator smashed its previous total for annual …

China urges firms to make generic versions of 34 drugs

June 25, 2019
Research and Development China, NHC, generic drugs, generics, patents, pharma

China’s National Health Commission (NHC) has urged generic drugmakers to pick up the production of 34 drugs that are not …


FDA expand Paragraph IV Patent Certifications List for generic drugmakers

June 19, 2019
Research and Development FDA, Hatch-Waxman act, generic drugs, generics, pharma

The FDA has said that it is expanding a database used by generic drugmakers to get information on when their …


Gilead struck anti-competitive deals to retain dominance in HIV market, lawsuit says

May 15, 2019
Research and Development AIDS, BMS, Gilead, HIV, Janssen, generic drugs

Gilead Sciences struck anti-competitive deals with Janssen and Britsol-Myers Squibb in an effort to retain dominance in the market for …


FDA approves record breaking 971 generic drugs in 2018

January 10, 2019
Manufacturing and Production FDA, approval, generic drugs, generics, regulation

The FDA approved a record 971 generic drugs in the 2018 fiscal year, giving the go-ahead to 110 generics in …


US FDA offers plan for global regulatory harmonisation for generic drugs

October 19, 2018
Medical Communications FDA, ICH, generic drugs, harmonisation, regulatory bodies

The US Food and Drug Administration (FDA) is offering a proposal to the International Council on Harmonisation (ICH) aimed at …


Non-profit generic drug company Civica Rx appoints former Amgen quality chief as new CEO

October 9, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Abbot, Amgen, Bayer, civica rx, generic drugs, hospitals

Civica Rx, a new not-for-profit generic drug company aimed at reducing the price of lifesaving medicines, has appointed former Amgen …


FDA weighs in to improve generic competition

June 27, 2017
Medical Communications, Sales and Marketing FDA, generic drugs, pricing debate

Since Scott Gottlieb was appointed Commissioner, the FDA has been on a marked push to tackle two areas: drug pricing …


Clinton announces plan to tackle “unjustified price hikes”

September 5, 2016
Sales and Marketing Drug pricing, Shkreli, US, clinton, generic drugs, president, price hikes

US Presidential candidate Hillary Clinton has outlined a wide-ranging set of proposals to tackle what she calls the “unjustified price …

Latest content